A Phase 1/2a Pilot Study of Intravesical TSD-001 for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
Phase of Trial: Phase I/II
Latest Information Update: 14 Jun 2018
At a glance
- Drugs Paclitaxel (Primary)
- Indications Bladder cancer; Bladder disorders; Genitourinary disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors TesoRx
- 17 Apr 2018 Planned End Date changed from 1 Sep 2018 to 1 Jun 2019.
- 17 Apr 2018 Planned primary completion date changed from 1 Aug 2018 to 1 Jun 2019.
- 17 Apr 2018 Status changed from not yet recruiting to recruiting.